Expand DNTH Menu
DNTH MENU

DNTH Latest Press Releases

-- March 12, 2026 --

Dianthus Therapeutics, Inc. Announces Closing of its Upsized $719 Million Underwritten Public Offering Including Full Exercise of Underwriters' Option to Purchase Additional Shares Globe Newswire 4:01 PM

-- March 10, 2026 --

Dianthus Therapeutics, Inc. Announces Pricing of Upsized $625 Million Underwritten Public Offering Globe Newswire 10:54 PM

-- March 9, 2026 --

Dianthus Therapeutics, Inc. Announces Proposed $400 Million Underwritten Public Offering Globe Newswire 4:01 PM
Dianthus Therapeutics Highlights Recent Business Achievements, Including GO Decision for Phase 3 CAPTIVATE CIDP Trial, and Reports Q4 and FY 2025 Financial Results Globe Newswire 7:09 AM
Dianthus Therapeutics Announces Early GO Decision Following Interim Responder Analysis in Phase 3 CAPTIVATE Trial of Claseprubart in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Globe Newswire 7:00 AM

-- March 8, 2026 --

Dianthus Therapeutics to Host Conference Call and Webcast to Discuss the Interim Responder Analysis Results of the Phase 3 Captivate Trial of Claseprubart in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Globe Newswire 5:00 PM

-- March 3, 2026 --

Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:01 PM

-- February 24, 2026 --

Dianthus Therapeutics to Participate in The TD Cowen 46th Annual Health Care Conference Globe Newswire 7:00 AM

-- February 5, 2026 --

Dianthus Therapeutics to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026 Globe Newswire 7:00 AM

-- January 5, 2026 --

Dianthus Therapeutics To Participate in the 44th Annual J.P. Morgan Healthcare Conference Globe Newswire 7:00 AM

-- December 23, 2025 --

Leads Biolabs And Dianthus Therapeutics Announce Initiation of Phase 1 Trial Of LBL-047 (DNTH212) In Healthy Volunteers and Patients With Systemic Lupus Erythematosus (SLE) Globe Newswire 6:00 AM

-- November 24, 2025 --

Dianthus Therapeutics To Participate in the 8th Annual Evercore Healthcare Conference Globe Newswire 7:00 AM

-- November 5, 2025 --

Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q3 Financial Results Globe Newswire 4:01 PM

-- November 4, 2025 --

Dianthus Therapeutics to Participate in Four Investor Conferences During November Globe Newswire 8:00 AM

-- October 29, 2025 --

Dianthus Therapeutics Highlights New Claseprubart Data Presented During 2025 AANEM Annual Meeting Globe Newswire 3:30 PM
Market Data Delayed 15 Minutes